Diversified Healthcare Trust (DHC) P/E Ratio History
Historical price-to-earnings valuation from 2000 to 2022
Loading P/E history...
DHC Valuation Context
How does the current P/E compare to historical and market benchmarks?
P/E Ratio Analysis
As of May 8, 2026, Diversified Healthcare Trust (DHC) trades at a price-to-earnings ratio of -6.8x, with a stock price of $8.09 and trailing twelve-month earnings per share of $-1.33.
The current P/E is 130% below its 5-year average of 22.7x. Over the past five years, DHC's P/E has ranged from a low of 0.6x to a high of 49.3x, placing the current valuation at the 0th percentile of its historical range.
Compared to the Real Estate sector median P/E of 24.2x, DHC trades at a 128% discount to its sector peers. The sector includes 171 companies with P/E ratios ranging from 1.1x to 196.6x.
Relative to the broader market, DHC trades at a notable discount to the S&P 500 median P/E of 25.1x. Investors should consider the company's growth prospects, competitive position, and earnings quality when evaluating whether the current valuation is justified.
For a comprehensive intrinsic value estimate using discounted cash flow analysis, see our DHC DCF Valuation Calculator →
Note: P/E ratio is just one valuation metric. It does not account for balance sheet strength, cash flow quality, or growth sustainability. Always conduct comprehensive due diligence before making investment decisions.
DHC P/E vs Peers
P/E ratio compared to closely matched public peers
| Company | Market Cap | P/E Ratio | PEG Ratio | EPS Growth (1Y) |
|---|---|---|---|---|
| $41B | 160.3 | - | +184%Best | |
| $149B | 153.3 | - | -11% | |
| $14B | 23.8 | 1.02Best | +25% | |
| $5B | 32.2 | - | +19% | |
| $2B | 15.3Lowest | - | +24% | |
| $9B | 25.2 | 1.19 | +96% | |
| $14B | 196.6 | - | -72% | |
| $4B | 24.9 | - | -4% | |
| $94M | 115.3 | - | -95% |
Peers sorted by market capitalization. P/E below peers may indicate undervaluation or lower growth expectations. Consider PEG ratio for growth-adjusted comparison.
DHC Historical P/E Data (2000–2022)
Quarterly P/E ratios calculated from closing price and TTM EPS
| Quarter | Date | Price | TTM EPS | P/E Ratio | vs Avg |
|---|---|---|---|---|---|
| FY2022 Q3 | Fri Sep 30 2022 00:00:00 GM | $0.99 | $1.75 | 0.6x | -97% |
| FY2022 Q2 | $1.82 | $1.71 | 1.1x | -95% | |
| FY2022 Q1 | $3.20 | $2.03 | 1.6x | -93% | |
| FY2021 Q4 | Fri Dec 31 2021 00:00:00 GM | $3.09 | $0.74 | 4.2x | -81% |
| FY2019 Q1 | Sun Mar 31 2019 00:00:00 GM | $11.78 | $0.34 | 34.6x | +58% |
| FY2018 Q4 | Mon Dec 31 2018 00:00:00 GM | $11.72 | $1.20 | 9.8x | -56% |
| FY2018 Q3 | Sun Sep 30 2018 00:00:00 GM | $17.56 | $1.97 | 8.9x | -59% |
| FY2018 Q2 | Sat Jun 30 2018 00:00:00 GM | $18.09 | $1.92 | 9.4x | -57% |
| FY2018 Q1 | Sat Mar 31 2018 00:00:00 GM | $15.66 | $1.47 | 10.7x | -51% |
| FY2017 Q4 | Sun Dec 31 2017 00:00:00 GM | $19.15 | $0.62 | 31.0x | +41% |
| FY2017 Q3 | Sat Sep 30 2017 00:00:00 GM | $19.55 | $0.53 | 37.1x | +69% |
| FY2017 Q2 | Fri Jun 30 2017 00:00:00 GM | $20.44 | $0.51 | 40.3x | +83% |
Average P/E for displayed period: 21.9x
See DHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs DHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare DHC vs WELL
Side-by-side business, growth, and profitability comparison vs Welltower Inc..
Start ComparisonDHC — Frequently Asked Questions
Quick answers to the most common questions about buying DHC stock.
Is DHC stock overvalued or undervalued?
DHC trades at -6.8x P/E, below its 5-year average of 22.7x. At the N/A percentile of historical range, the stock is priced at a discount to its own history.
How does DHC's valuation compare to peers?
Diversified Healthcare Trust P/E of -6.8x compares to sector median of 24.2x. The discount suggests lower growth expectations or higher risk.
What is DHC's PEG ratio?
DHC PEG ratio is N/A. Above 2.0 indicates premium valuation relative to growth rate. Historical P/E data spans 2000-2022.